SRINATH TADAKAMALLA: Open Payments
NPI 1184691305 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,531 in 47 payments from 8 companies in 2025. Trend: 2023 $12,797 · 2024 $601 · 2025 $18,531
Speaker / faculty: $9,900Honoraria: $5,800Travel & lodging: $1,511Food & beverage: $1,310Education: $9
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 20 | $11,157 |
| Axsome Therapeutics, Inc. | 3 | $5,861 |
| Alpha Cognition USA, Inc. | 1 | $900 |
| Vanda Pharmaceuticals Inc. | 8 | $260 |
| Otsuka America Pharmaceutical, Inc. | 12 | $162 |
| Abbott Laboratories | 1 | $141 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| PROTEGA PHARMACEUTIALS INC | 1 | $24 |
Products named: NUPLAZID, Zunveyl, FANAPT, REXULTI, AMPLATZER AMULET, INGREZZA, ROXYBOND.
Industry payments across MO — which companies pay providers there.
